LAGOS, July 24- A Liberian man in his 40 s is being tested for the deadly Ebola virus in Nigeria's commercial capital of Lagos, a megacity of 21 million people, the Lagos State Health Ministry said on Thursday.» Read More
Bob Leeds, Sea of Green Farms, is a licensed marijuana grower in the state of Washington. Leeds discusses his upstart progression and says he has invested about $2 million in the process to date.
Teresa Yuan, King TV, reports from one of the first legal marijuana shops in the state of Washington.
In preparatory documents posted on the agency's website on Tuesday, FDA reviewers said laparoscopic power morcellator devices, which are used to treat uterine fibroids, allow for less invasive surgeries, shorter recovery time and fewer wound site infections.
July 8- German drugmaker Boehringer Ingelheim said its experimental blood cancer drug met its main goal in a mid-stage trial and improved overall survival rate among patients.
July 8- Anacor Pharmaceutical Inc said the U.S. Food and Drug Administration approved its treatment for a fungal infection of the nail, sending the drug developer's shares up about 9 percent in premarket trade. Onychomycosis is a progressive, recurring fungal infection of the nail and nail bed and affects about 35 million people in the United States, Anacor said.
July 8- German drugmaker Boehringer Ingelheim said its experimental blood cancer drug met its main goal in a mid-stage trial. Data showed the cancer was not found in 31 percent of the patients treated with the drug volasertib along with a chemotherapy agent versus 13.3 percent of patients who were administered the chemotherapy alone.
CNBC's Scott Cohn follows up on his investigation into the high cost of prescription drugs and reports how consumers can protect themselves from getting fake medicine.
July 3- Spectrum Pharmaceuticals Inc's drug for the treatment of an aggressive form of blood cancer was granted an accelerated approval by the U.S. Food and Drug Administration on Thursday. Beleodaq is the third drug to win approval for the condition since 2009, the other two being Spectrum's injection Folotyn and Celgene Corp's drug Istodax.
NEW YORK, July 2- Jamie Dimon, chairman and chief executive of JPMorgan Chase& Co, plans to be out of the office for at least half of his planned two-month course of radiation treatment and chemotherapy for throat cancer, a spokesman said on Wednesday.
July 2- Drug developer Bind Therapeutics said it ended a partnership with Amgen Inc to develop targeted cancer therapy due to unsatisfactory results.
NEW YORK, July 1- JPMorgan Chase& Co Chief Executive Jamie Dimon said he has been diagnosed with throat cancer but that the ailment is curable and he plans to remain actively involved in the business and continue to run the largest U.S. bank.
NEW YORK, July 1- JPMorgan Chase& Co Chief Executive Jamie Dimon told the bank's employees and shareholders on Tuesday that he has been diagnosed with curable throat cancer. Dimon has notified JPMorgan's board. Dimon became chairman of the board on Dec. 31, 2006, and has been CEO and president since Dec. 31, 2005.
NEW YORK, July 1- JPMorgan Chase& Co Chief Executive Officer Jamie Dimon has told the bank's employees and shareholders he has been diagnosed with curable throat cancer, Dow Jones reported on Tuesday. Dimon has notified JPMorgan's board, Dow Jones added. A JPMorgan spokeswoman did not immediately respond to a request for comment.
GENEVA, July 1- The number of deaths attributed to an epidemic of Ebola virus in Guinea, Liberia and Sierra Leone stood at 467 by Monday, out of 759 known cases in total, the World Health Organization said on Tuesday.
July 1- Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.
AGENUS BRAIN CANCER VACCINE NEARLY DOUBLES SURVIVAL RATE IN. July 1- Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.
Pro-life and pro-choice demonstrators eagerly awaited the U.S. Supreme Court decision on contraception on Monday. CNBC's Hampton Pearson reports on the ruling.
BUZZ-DICERNA PHARMACEUTICALS INC: PROMISING ANIMAL TRIAL DATA@** Drug developer's shares up 13 pct at $21.35. **Company presents positive preclinical data on its experimental liver disease drug. **The animal trials showed that Dicerna's drug blocked a gene that is found in patients with a rare inherited liver disorder called PH1.
WASHINGTON, June 27- The U.S. Food and Drug Administration said on Friday it has approved MannKind Corp's inhaled insulin Afrezza, capping an arduous journey for the company and its octogenarian founder, Alfred Mann. It acts more rapidly than traditional injected insulin sold by Eli Lilly and Co and Denmark's Novo Nordisk.
June 26- Acorda Therapeutics Inc said Actavis Plc plans to market a generic version of Acorda's multiple sclerosis treatment, Ampyra. Ampyra, which was approved in January 2010, had net sales of $72.5 million in the first quarter ended March 31.